Moore Capital Management, LP Axogen, Inc. Transaction History

Moore Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $427,250 - $956,250	-25,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $1.81 Million - $2.63 Million	-50,000 Reduced 66.67%	25,000 $1.26 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $610,000 - $1.01 Million	25,000 Added 50.0%	75,000 $2.74 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $925,000 - $1.43 Million	50,000	50,000 $1.42 Million

129

35.8M

79.1K

500

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $583M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.